tumCV Cancer Research Results
tumCV, Cell Viability: Click to Expand ⟱
| Source: |
| Type: |
Cell Viability
|
HCC, Hepatocellular Carcinoma: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
ATP↓, TumCD↑, toxicity↓, eff↑, tumCV↓, Dose↝,
tumCV↓, Apoptosis↑, TumCP↓, TumCMig↓, TumCI↓, MMP2↓, MMP9↓, lipid-P↓,
tumCV↓, Apoptosis↑, TumAuto↑, p‑Akt↓,
AMPK↑, CaMKII
↑, tumCV↓, Akt↓, mTOR↓, ROS↑,
tumCV↓, SLC6A3?,
*hepatoP↑, *ROS↓, tumCV↓,
tumCV↓, TumAuto↑, selectivity↑, mt-ROS↑, MMP↓, LC3B↑, Beclin-1↓, p62↓, PINK1↑, PARK2↑, eff↓, p‑MAPK↑,
TumCG↓, tumCV↓, Apoptosis↑, P53↑, NF-kB↓,
tumCV↓, TumCMig↓, *ALAT↓, *AST↓, *ALP↓, *Bil↓, *CEA↓, *lipid-P↓, *TNF-α↓, *IL1β↓, NF-kB↓, CXCR3↓, HRAS↓, KRAS↓, Ki-67↓, *GSH↑, *GPx↑, *SOD↑, *NRF2↑, P53↑, BAX↑, DR4↑, DR5↑,
tumCV↓, Apoptosis↑, TumCMig↓, TumCG↓, survivin↓, mtDam↑, Casp3↑,
| - |
vitro+vivo, |
HCC, |
HepG2 |
|
|
|
- |
NA, |
HCC, |
SK-HEP-1 |
|
|
|
tumCV↓, TumCCA↓, Casp3↑, Cyt‑c↑, TumCG↓, Dose↝,
tumCV↓, TumCG↓, pH↑, eff↑, Imm↑,
| - |
in-vitro, |
HCC, |
HepG2 |
|
|
|
- |
in-vitro, |
HCC, |
HUH7 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
TumCMig↓, TumCI↓, ER Stress↑, selectivity↑, tumCV↓, ROS↑, GSH↓, eff↓, Ca+2↑, MAPK↑, CHOP/DDIT3↑, Dose↝,
| - |
in-vitro, |
HCC, |
SMMC-7721 cell |
|
|
|
- |
in-vitro, |
HCC, |
HUH7 |
|
|
|
- |
in-vitro, |
HCC, |
HepG2 |
|
|
|
tumCV↓, GlucoseCon↓, lactateProd↓, ChemoSen↑, PKM2↓, Glycolysis↓,
| - |
in-vitro, |
HCC, |
HepG2 |
|
|
|
- |
in-vitro, |
BC, |
MCF7 |
|
|
|
- |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
Nor, |
HEK293 |
|
|
|
P53↑, lipid-P↑, GSH↓, ROS↑, MMP↓, BAX↑, Casp3↑, Casp9↑, Bcl-2↓, tumCV↓, selectivity↑,
Showing Research Papers: 1 to 15 of 15
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 15
Pathway results for Effect on Cancer / Diseased Cells:
NA, unassigned(tgid=0) ⓘ
CXCR3↓, 1,
Redox & Oxidative Stress(tgid=1) ⓘ
GSH↓, 2, lipid-P↓, 1, lipid-P↑, 1, PARK2↑, 1, ROS↑, 3, mt-ROS↑, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
ATP↓, 1, MMP↓, 2, mtDam↑, 1, PINK1↑, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
AMPK↑, 1, GlucoseCon↓, 1, Glycolysis↓, 1, lactateProd↓, 1, PKM2↓, 1,
Cell Death(tgid=5) ⓘ
Akt↓, 1, p‑Akt↓, 1, Apoptosis↑, 4, BAX↑, 2, Bcl-2↓, 1, Casp3↑, 3, Casp9↑, 1, Cyt‑c↑, 1, DR4↑, 1, DR5↑, 1, MAPK↑, 1, p‑MAPK↑, 1, survivin↓, 1, TumCD↑, 1,
Kinase & Signal Transduction(tgid=6) ⓘ
CaMKII
↑, 1,
Transcription & Epigenetics(tgid=7) ⓘ
tumCV↓, 15,
Protein Folding & ER Stress(tgid=8) ⓘ
CHOP/DDIT3↑, 1, ER Stress↑, 1,
Autophagy & Lysosomes(tgid=9) ⓘ
Beclin-1↓, 1, LC3B↑, 1, p62↓, 1, TumAuto↑, 2,
DNA Damage & Repair(tgid=10) ⓘ
P53↑, 3,
Cell Cycle & Senescence(tgid=11) ⓘ
TumCCA↓, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
HRAS↓, 1, mTOR↓, 1, TumCG↓, 4,
Migration(tgid=13) ⓘ
Ca+2↑, 1, Ki-67↓, 1, KRAS↓, 1, MMP2↓, 1, MMP9↓, 1, TumCI↓, 2, TumCMig↓, 4, TumCP↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
Imm↑, 1, NF-kB↓, 2,
Cellular Microenvironment(tgid=17) ⓘ
pH↑, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
ChemoSen↑, 1, Dose↝, 3, eff↓, 2, eff↑, 2, selectivity↑, 3,
Clinical Biomarkers(tgid=22) ⓘ
Ki-67↓, 1, KRAS↓, 1, SLC6A3?, 1,
Functional Outcomes(tgid=23) ⓘ
toxicity↓, 1,
Total Targets: 63
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
Bil↓, 1, GPx↑, 1, GSH↑, 1, lipid-P↓, 1, NRF2↑, 1, ROS↓, 1, SOD↑, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
ALAT↓, 1,
Migration(tgid=13) ⓘ
CEA↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
IL1β↓, 1, TNF-α↓, 1,
Clinical Biomarkers(tgid=22) ⓘ
ALAT↓, 1, ALP↓, 1, AST↓, 1, Bil↓, 1, CEA↓, 1,
Functional Outcomes(tgid=23) ⓘ
hepatoP↑, 1,
Total Targets: 17
Scientific Paper Hit Count for: tumCV, Cell Viability
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:10 Cells:% prod#:% Target#:897 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page